• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘氨酰-tRNA 合成酶(GARS)的表达与前列腺癌的进展相关,其抑制作用可降低体外迁移和侵袭。

Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.

机构信息

Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Departments of Oncology, Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.

出版信息

Int J Mol Sci. 2023 Feb 21;24(5):4260. doi: 10.3390/ijms24054260.

DOI:10.3390/ijms24054260
PMID:36901698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10001614/
Abstract

Glycyl-tRNA synthetase (GARS) is a potential oncogene associated with poor overall survival in various cancers. However, its role in prostate cancer (PCa) has not been investigated. Protein expression of GARS was investigated in benign, incidental, advanced, and castrate-resistant PCa (CRPC) patient samples. We also investigated the role of GARS in vitro and validated GARS clinical outcomes and its underlying mechanism, utilizing The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA PRAD) database. Our data revealed a significant association between GARS protein expression and Gleason groups. Knockdown of in PC3 cell lines attenuated cell migration and invasion and resulted in early apoptosis signs and cellular arrest in S phase. Bioinformatically, higher expression was observed in TCGA PRAD cohort, and there was significant association with higher Gleason groups, pathological stage, and lymph nodes metastasis. High expression was also significantly correlated with high-risk genomic aberrations such as , , , , mutations, and , , and gene fusions. Gene Set Enrichment Analysis (GSEA) of through the TCGA PRAD database provided evidence for upregulation of biological processes such as cellular proliferation. Our findings support the oncogenic role of GARS involved in cellular proliferation and poor clinical outcome and provide further evidence for its use as a potential biomarker in PCa.

摘要

甘氨酰-tRNA 合成酶(GARS)是一种与多种癌症患者总体生存率差相关的潜在致癌基因。然而,其在前列腺癌(PCa)中的作用尚未得到研究。我们研究了良性、偶发、晚期和去势抵抗性前列腺癌(CRPC)患者样本中 GARS 的蛋白表达情况。我们还利用癌症基因组图谱前列腺腺癌(TCGA PRAD)数据库研究了 GARS 在体外的作用及其潜在机制,并验证了 GARS 的临床结果及其潜在机制。我们的数据显示,GARS 蛋白表达与 Gleason 分组之间存在显著相关性。在 PC3 细胞系中敲低 GARS 可减弱细胞迁移和侵袭,并导致早期凋亡迹象和 S 期细胞停滞。从生物信息学角度来看,在 TCGA PRAD 队列中观察到更高的 表达水平,并且与更高的 Gleason 分组、病理分期和淋巴结转移显著相关。高 表达水平也与高风险基因组异常显著相关,如 、 、 、 突变,以及 、 和 基因融合。通过 TCGA PRAD 数据库进行的 基因集富集分析(GSEA)提供了证据,表明细胞增殖等生物学过程的上调。我们的研究结果支持 GARS 的致癌作用涉及细胞增殖和不良临床结局,并为其作为前列腺癌潜在生物标志物的用途提供了进一步证据。

相似文献

1
Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.甘氨酰-tRNA 合成酶(GARS)的表达与前列腺癌的进展相关,其抑制作用可降低体外迁移和侵袭。
Int J Mol Sci. 2023 Feb 21;24(5):4260. doi: 10.3390/ijms24054260.
2
Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.剪接因子 4(CPSF4)表达与体外增强的前列腺癌细胞迁移和细胞周期失调有关。
Int J Mol Sci. 2023 Aug 19;24(16):12961. doi: 10.3390/ijms241612961.
3
Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.功能受损是神经病变相关甘氨酰 - tRNA合成酶突变的常见特征。
Hum Mutat. 2014 Nov;35(11):1363-71. doi: 10.1002/humu.22681.
4
Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer.锯齿状RNA效应分子(SRRT)与前列腺癌进展相关,是致命性前列腺癌预后不良的一个预测指标。
Cancers (Basel). 2023 May 22;15(10):2867. doi: 10.3390/cancers15102867.
5
Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.甘氨酰-tRNA合成酶突变的功能分析表明,tRNA充电酶在外周轴突中起关键作用。
J Neurosci. 2006 Oct 11;26(41):10397-406. doi: 10.1523/JNEUROSCI.1671-06.2006.
6
Elevated LAMTOR4 Expression Is Associated with Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro.LAMTOR4 表达升高与致命性前列腺癌相关,其敲低可减少体外细胞增殖、侵袭和迁移。
Int J Mol Sci. 2024 Jul 25;25(15):8100. doi: 10.3390/ijms25158100.
7
ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro.ARPC1B 与致命性前列腺癌相关,其抑制作用可降低体外细胞侵袭和迁移。
Int J Mol Sci. 2022 Jan 27;23(3):1476. doi: 10.3390/ijms23031476.
8
GARS is implicated in poor survival and immune infiltration of hepatocellular carcinoma.甘氨酰-tRNA合成酶与肝细胞癌的不良预后和免疫浸润有关。
Cell Signal. 2022 Jun;94:110302. doi: 10.1016/j.cellsig.2022.110302. Epub 2022 Mar 7.
9
Glycyl-tRNA Synthetase Induces Psoriasis-Like Skin by Facilitating Skin Inflammation and Vascular Endothelial Cell Angiogenesis.甘氨酰-tRNA 合成酶通过促进皮肤炎症和血管内皮细胞血管生成诱导银屑病样皮肤。
J Invest Dermatol. 2024 Apr;144(4):774-785.e10. doi: 10.1016/j.jid.2023.09.270. Epub 2023 Oct 11.
10
Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.甘氨酰 - tRNA合成酶(GARS)的复合杂合突变导致线粒体呼吸链功能障碍。
PLoS One. 2017 Jun 8;12(6):e0178125. doi: 10.1371/journal.pone.0178125. eCollection 2017.

引用本文的文献

1
Glycyl-tRNA Synthetase as a Target for Antiviral Drug Screening Against Influenza Virus.甘氨酰 - tRNA合成酶作为抗流感病毒药物筛选的靶点
Int J Mol Sci. 2025 Mar 23;26(7):2912. doi: 10.3390/ijms26072912.
2
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer.前列腺癌中氨基酸代谢的细胞信号传导
Int J Mol Sci. 2025 Jan 17;26(2):776. doi: 10.3390/ijms26020776.
3
Prognostic value of in bladder cancer and its role in the tumor microenvironment.[具体内容]在膀胱癌中的预后价值及其在肿瘤微环境中的作用。 (原文“Prognostic value of in bladder cancer”中“of”后缺少具体内容)

本文引用的文献

1
GARS is implicated in poor survival and immune infiltration of hepatocellular carcinoma.甘氨酰-tRNA合成酶与肝细胞癌的不良预后和免疫浸润有关。
Cell Signal. 2022 Jun;94:110302. doi: 10.1016/j.cellsig.2022.110302. Epub 2022 Mar 7.
2
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities.p53 重新激活在前列腺癌中的治疗潜力:策略与机遇
Eur J Pharmacol. 2022 Mar 15;919:174807. doi: 10.1016/j.ejphar.2022.174807. Epub 2022 Feb 10.
3
UALCAN: An update to the integrated cancer data analysis platform.
Transl Cancer Res. 2024 Jun 30;13(6):2825-2846. doi: 10.21037/tcr-23-2148. Epub 2024 Jun 27.
4
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.弗拉西尼布:一种杯吡咯衍生物,可降低A549细胞源性非小细胞肺癌肿瘤,作为甘氨酰tRNA合成酶的配体,这是肿瘤学中的一个新分子靶点。
Front Pharmacol. 2024 Jan 3;14:1258108. doi: 10.3389/fphar.2023.1258108. eCollection 2023.
UALCAN:一个集成癌症数据分析平台的更新。
Neoplasia. 2022 Mar;25:18-27. doi: 10.1016/j.neo.2022.01.001. Epub 2022 Jan 22.
4
ETS factors in prostate cancer.ETS 因素与前列腺癌。
Cancer Lett. 2022 Apr 1;530:181-189. doi: 10.1016/j.canlet.2022.01.009. Epub 2022 Jan 14.
5
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
6
Conjoint analysis of circulating tumor cells and solid tumors for exploring potential prognostic markers and constructing a robust novel predictive signature for breast cancer.循环肿瘤细胞与实体瘤的联合分析,用于探索潜在的预后标志物并构建强大的乳腺癌新型预测特征。
Cancer Cell Int. 2021 Dec 25;21(1):708. doi: 10.1186/s12935-021-02415-8.
7
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.高通量和多阶段鉴定自身抗体在早期乳腺癌及亚型诊断中的应用。
Cancer Sci. 2022 Feb;113(2):770-783. doi: 10.1111/cas.15227. Epub 2021 Dec 9.
8
A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients.一种新型线粒体相关核基因特征可预测肺腺癌患者的总生存期。
Front Cell Dev Biol. 2021 Oct 25;9:740487. doi: 10.3389/fcell.2021.740487. eCollection 2021.
9
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.TNMplot.com:一个用于比较正常、肿瘤和转移组织中基因表达的网络工具。
Int J Mol Sci. 2021 Mar 5;22(5):2622. doi: 10.3390/ijms22052622.
10
Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics.采用 iTRAQ 蛋白质组学技术在尿液中发现用于诊断尿路上皮癌的新型蛋白生物标志物
J Proteome Res. 2021 May 7;20(5):2953-2963. doi: 10.1021/acs.jproteome.1c00164. Epub 2021 Mar 29.